Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Vaxcyte, Inc.
  6. News
  7. Summary
    PCVX   US92243G1085

VAXCYTE, INC.

(PCVX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Vaxcyte

10/22/2021 | 04:52pm EST


ę MT Newswires 2021
All news about VAXCYTE, INC.
11/11Vaxcyte to Present at Upcoming Investor Conferences
GL
11/10Vaxcyte Investor Presentation November 2021
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update - For..
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/10VAXCYTE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/10Vaxcyte, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
10/28VAXCYTE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/28Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
AQ
10/28Vaxcyte, Inc. Announces Board Changes
CI
10/22INSIDER SELL : Vaxcyte
MT
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -101 M - -
Net Debt 2021 - - -
P/E ratio 2021 -10,2x
Yield 2021 -
Capitalization 1 048 M 1 048 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 1 048x
Nbr of Employees 58
Free-Float 84,3%
Chart VAXCYTE, INC.
Duration : Period :
Vaxcyte, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VAXCYTE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 19,86 $
Average target price 50,50 $
Spread / Average Target 154%
EPS Revisions
Managers and Directors
Grant E. Pickering Chief Executive Officer & Director
Andrew L. Guggenhime President & Chief Financial Officer
Carlos V. Paya Chairman
Romulo Colindres Chief Medical Officer
Jim Wassil Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
VAXCYTE, INC.-25.25%1 048
GILEAD SCIENCES, INC.20.61%88 146
BIONTECH SE326.89%84 049
REGENERON PHARMACEUTICALS33.17%67 266
WUXI APPTEC CO., LTD.24.40%64 416
VERTEX PHARMACEUTICALS-22.32%46 678